Drive-Through Screening Center for COVID-19: a Safe and Efficient Screening System against Massive Community Outbreak

Journal of Korean Medical Science 2020³â 35±Ç 11È£ p.123 ~ p.123

±Ç±âÅÂ(Kwon Ki-Tae) - Kyungpook National University School of Medicine Department of Internal Medicine
°íÀçÈÆ(Ko Jae-Hoon) - Sungkyunkwan University School of Medicine Samsung Medical Center Department of Medicine
½ÅÈñÁØ(Shin Hee-Jun) - Soonchunhyang University Hospital Department of Emergency Medicine
¼º¹Î±â(Sung Min-Ki) - Sejong University Department of Architectural Engineering
±èÁø¿ë(Kim Jin-Yong) - Incheon Medical Center Department of Internal Medicine

Abstract

As the coronavirus disease 2019 (COVID-19) outbreak is ongoing, the number of individuals to be tested for COVID-19 is rapidly increasing. For safe and efficient screening for COVID-19, drive-through (DT) screening centers have been designed and implemented in Korea. Herein, we present the overall concept, advantages, and limitations of the COVID-19 DT screening centers. The steps of the DT centers include registration, examination, specimen collection, and instructions. The entire service takes about 10 minutes for one testee without leaving his or her cars. Increased testing capacity over 100 tests per day and prevention of cross-infection between testees in the waiting space are the major advantages, while protection of staff from the outdoor atmosphere is challenging. It could be implemented in other countries to cope with the global COVID-19 outbreak and transformed according to their own situations.

Å°¿öµå

Drive-through, Screening, SARS-CoV-2, COVID-19, Outbreak
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
DT screening centers have been implemented in Korea for safer and more efficient screening for COVID-19. It could be implemented in other countries to cope with the global COVID-19 outbreak and adjusted according to the regional situations.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå